Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Hapten Sciences
AddedFeb 17, 2024
UpdatedJun 18, 2026
Hapten Sciences

Hapten Sciences

Pre-Seed

Hapten Sciences: A Memphis-based biopharmaceutical firm innovating for global health.

HQ
Memphis, TN, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Hapten Sciences, founded in Memphis, Tennessee, is a privately-held biopharmaceutical company dedicated to the development of novel, early-stage products aimed at improving global health and well-being. The company focuses on identifying innovative solutions that address significant medical needs, with a particular emphasis on efficient product development. Their market focus includes various therapeutic areas where there is a high demand for new and effective treatments.

Notable individuals affiliated with Hapten Sciences include experienced professionals from the biopharmaceutical industry. The company has garnered attention for its strategic approach to product development and its potential impact on global health. Key achievements include the successful identification and advancement of promising early-stage products. Overall, Hapten Sciences is making strides in the biopharmaceutical sector by contributing to the development of groundbreaking health solutions.

Hapten Sciences - Similar Companies

Agile Sciences logo

Agile Sciences

agilesci.com

Gradient Pharmaceuticals logo

Gradient Pharmaceuticals

ISI Life Sciences logo

ISI Life Sciences

EDP Biotech logo

EDP Biotech

edpbiotech.com

AgGenetics logo

AgGenetics

BiotechInnova logo

BiotechInnova

biotechinnova.com

NightHawk Biosciences logo

NightHawk Biosciences

SphynKx Therapeutics logo

SphynKx Therapeutics

Spheringenics logo

Spheringenics

Hengrui Therapeutics logo

Hengrui Therapeutics

Merganser Biotech logo

Merganser Biotech

Brighton Biotech logo

Brighton Biotech

Amplified Sciences logo

Amplified Sciences

BioHealthonomics logo

BioHealthonomics

GPB Scientific logo

GPB Scientific

Hapten Sciences - Quick Facts

Who are Hapten Sciences' competitors?

Companies similar to Hapten Sciences include Agile Sciences, Gradient Pharmaceuticals, ISI Life Sciences and EDP Biotech.

When was Hapten Sciences founded?

Hapten Sciences was founded in 2010.

Where is Hapten Sciences' headquarters located?

Hapten Sciences' headquarters is located in Memphis, TN, US.

When was Hapten Sciences' last funding round?

Hapten Sciences' most recent funding round was for $1.2M (USD) in January 2016.

How much has Hapten Sciences raised to-date?

As of Jan 12, 2016, Hapten Sciences has raised a total of $3.1M (USD).

How many employees does Hapten Sciences have?

Hapten Sciences has 2 employees as of Feb 5, 2024.

Hapten Sciences - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified